glp-1 drugs pills Ro Launches Wegovy® Pill Through Integration with Novo Nordisk Eli Lilly to seek approval

manufactured in cGMP-certified facilities, third-party tested for purity, and non-GMO, gluten-free, with zero artificial additives or fillers

Results Patients with a high cumulative dose of GLP-1 agonist are associated with a higher risk of developing drug-induced pancreatitis associated with GLP-1 agonists, indicated by a statistically significant odds ratio

Curious about Microdosing GLP-1

ANALYSIS METHODOLOGY For a deeper understanding of where off-label GLP-1 uses are emerging, Storyful Intelligence analyzed 29.9k mentions across conversations on X, Facebook, Reddit, and Instagram, from February 1, 2024, to March 24, 2025

Alabamas attorney general recently filed a lawsuit against a medical spa alleging that it administered unapproved versions of GLP-1 weight loss drugs to patients without informing them that the formulations were not authorized by the FDA

GLP-1s are trending as the next big thing in weight loss